晚期口腔鳞癌患者独立预后因素及生存预测模型的建立

doi:10.19439/j.sjos.2019.05.017

摘要/Abstract

摘要： 目的探讨晚期口腔鳞癌患者的独立预后因素并构建生存预测模型。方法收集117例晚期口腔鳞癌患者的一般资料及既往病史,所有患者均行口腔鳞癌切除术并联合放疗,根据患者情况进行羟基喜树碱及平阳霉素化疗。所有患者随访时间为手术结束至术后5年,记录患者生存情况,分析晚期口腔鳞癌患者预后的独立危险因素。采用SPSS 20.0软件包对数据进行统计学分析。结果随访期间,2例因其他原因死亡,4例因失访而剔除。剩余111例患者中, 42例死亡,69例存活,生存率为62.16%;年龄、T分期及M分期不同的晚期口腔鳞癌患者生存情况无显著差异（P>0.05）;性别、组织分化程度、N分期及化疗情况不同的晚期口腔鳞癌患者生存情况差异显著（P<0.05）;性别、N分期及是否联合羟基喜树碱与平阳霉素化疗是晚期口腔鳞癌患者生存情况的独立危险因素（P<0.05）;组织分化程度不是晚期口腔鳞癌患者生存情况的独立危险因素（P>0.05）;性别、N分期及是否联合羟基喜树碱与平阳霉素化疗的生存曲线对晚期口腔鳞癌患者生存情况具有一定预测作用。结论性别、N分期及是否联合羟基喜树碱与平阳霉素化疗是晚期口腔鳞癌患者生存情况的独立危险因素;性别、N分期及是否联合羟基喜树碱与平阳霉素化疗的生存曲线,可作为晚期口腔鳞癌患者的生存预测模型。

关键词: 晚期, 口腔鳞癌, 预后, 独立危险因素, 生存预测

Abstract: PURPOSE: To investigate the independent prognostic factors and establish survival prediction model for advanced oral squamous cell carcinoma (OSCC). METHODS: At the time of admission, the general information and past medical history of 177 patients with advanced OSCC were collected in detail. All patients underwent radical resection. After surgery, radiotherapy and chemotherapy with hydroxycampothecin (HCPT) and pingyangmycin (PYM) were performed according to the patient's condition. All patients were followed up for 5 years after surgery, and the survival rate during that period and the risk factors for prognosis were analyzed. The data were analyzed by SPSS 20.0 software package. RESULTS: During the follow-up period, 2 patients died due to other causes, 4 were excluded due to lost to follow-up, 42 of the remaining 111 patients died, 69 survived, the total survival rate was 62.16%. The survival status of patients with advanced OSCC with different age, T stage and M stage had no significant difference (P>0.05), while significant difference was found among patients with different gender, tissue differentiation degree, N stage and chemotherapy (P<0.05). Gender, N stage and HCPT in combination of PYM chemotherapy were independent risk factors (P<0.05), while histological differentiation degree was not an independent risk factor for survival of patients (P>0.05). The survival curves of gender, N stage and HCPT in combination of PYM chemotherapy had certain predictive value on the survival of patients with advanced OSCC. CONCLUSIONS: Gender, N stage and HCPT in combination of PYM chemotherapy are independent risk factors for the survival of patients with advanced OSCC, and their survival curves can be used as a survival prediction model.

Key words: Advanced stage, Oral squamous cell carcinoma, Prognosis, Independent risk factors, Survival prediction

中图分类号:

R739.8

丁红忠, 许从平, 周永敏. 晚期口腔鳞癌患者独立预后因素及生存预测模型的建立[J]. 上海口腔医学, 2019, 28(5): 536-540.

DING Hong-zhong, XU Cong-ping, ZHOU Yong-min. Independent prognostic factors and survival prediction model for 117 patients with advanced oral squamous cell carcinoma[J]. Shanghai Journal of Stomatology, 2019, 28(5): 536-540.

参考文献

[1] Schilling C, Stoeckli SJ, Haerle SK, et al.Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer[J]. Eur J Cancer, 2015, 51(18): 2777-2784.
[2] Lee MR, Lin C, Lu CC, et al.YC-1 induces G0/G1 phase arrest and mitochondria-dependent apoptosis in cisplatin-resistant human oral cancer CAR cells[J]. Biomedicine (Taipei), 2017, 7(2): 12.
[3] Tsai SC, Lu CC, Lee CY, et al.AKT serine/threonine protein kinase modulates bufalin-triggered intrinsic pathway of apoptosis in CAL 27 human oral cancer cells[J]. Int J Oncol, 2015, 41(5): 1683-1692.
[4] Petti S, Scully C.How many individuals must be screened to reduce oral cancer mortality rate in the Western context? A challenge[J]. Oral Dis, 2015, 21(8): 949-954.
[5] Bobdey S, Ganesh B, Mishra P, et al.Role of monocyte count and neutrophil-to-lymphocyte ratio in survival of oral cancer patients[J]. Int Arch Otorhinolaryngol, 2017, 21(1): 21-27.
[6] 崔力方, 刘红刚. 人乳头状瘤病毒相关头颈部鳞状细胞癌研究进展[J]. 中华病理学杂志, 2016, 45(10): 734-737.
[7] Kishikawa H, Sato K, Yamauchi T, et al.Incidence and risk factors for colorectal neoplasia in patients with oral squamous cell carcinoma[J]. Colorectal Dis, 2014, 16(11): 888-895.
[8] 肖水芳, 赵欣, 张俊波, 等. 等离子射频技术辅助经口微创手术治疗口咽及口腔恶性肿瘤的临床观察[J]. 临床耳鼻咽喉头颈外科杂志, 2017, 31(22): 1705-1710.
[9] Sento S, Sasabe E, Yamamoto T.Application of a persistent heparin treatment inhibits the malignant potential of oral squamous carcinoma cells induced by tumor cell-derived exosomes[J]. PloS One, 2016, 11(2): e0148454.
[10] Taghavi N, Yazdi I.Prognostic factors of survival rate in oral squamous cell carcinoma: clinical, histologic, genetic and molecular concepts[J]. Arch Iran Med, 2015, 18(5): 314-319.
[11] Wang X, Xu J, Wang L, et al.The role of cigarette smoking and alcohol consumption in the differentiation of oral squamous cell carcinoma for the males in China[J]. J Cancer Res Ther, 2015, 11(1): 141-145.
[12] Chung AS J, Mccammon KA .Outlet procedures in female cancer survivors for the treatment of stress incontinence: differences in indications, technique, and outcome for the cancer survivor[J]. Curr Bladder Dysfunct Rep, 2017, 12(2): 153-158.
[13] Tong K, Pellón-Cárdenas O, Sirihorachai VR, et al.Degree of tissue differentiation dictates susceptibility to BRAF-driven colorectal cancer[J]. Cell Rep, 2017, 21(13): 3833-3845.
[14] Langhout GC, Spliethoff JW, Schmitz SJ, et al.Differentiation of healthy and malignant tissue in colon cancer patients using optical spectroscopy: A tool for image-guided surgery[J]. Laser Surge Med, 2015, 47(7): 559-565.
[15] Somnay YR, Yu XM, Lloyd RV, et al.Notch3 expression correlates with thyroid cancer differentiation, induces apoptosis, and predicts disease prognosis[J]. Cancer, 2017, 123(5): 769-782.
[16] Pedersen NJ, Jensen DH, Hedbäck N, et al.Staging of early lymph node metastases with the sentinel lymph node technique and predictive factors in T1/T2 oral cavity cancer: A retrospective single-center study[J]. Head Neck, 2016, 38(Suppl 1): E1033-1040.
[17] Hwang SH, Kim HI, Song JS, et al.The ratio-based N staging system can more accurately reflect the prognosis of T4 gastric cancer patients with D2 lymphadenectomy compared with the 7th American joint committee on cancer/union for international cancer control staging system[J]. J Gastric Cancer, 2016, 16(4): 207-214.
[18] Welters MJ, Sluis TC, Hélène van Meir, et al. Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses [J]. Sci Transl Med, 2016, 8(334): 334ra52.
[19] Harris JR, Hellman S.Observations on survival curve analysis with particular reference to breast cancer treatment[J]. Cancer, 1986, 57(5): 925-928.
[20] Ebeling M, Rau R, Baudisch A.Rectangularization of the survival curve reconsidered: The maximum inner rectangle approach[J]. Popul Stud (Camb), 2018, 72(3): 369-379.